Cite Filings / XLO / 0000902664-25-002744

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Xilio Therapeutics, Inc. Filed 2025-06-17 Acc 0000902664-25-002744

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-06-18 4 Director bought 70,000 shares at an average $0.69 ($48,085)
2025-06-18 4 PRESIDENT AND CEO bought 36,289 shares at $0.68 ($24,680)
2025-06-18 4/A Changes in Ownership
2025-06-17 SCHEDULE 13G Statement of Beneficial Ownership
2025-06-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-06-12 4 Options or other derivatives

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…